Sarah Cardozo Duncan
Sarah Cardozo DuncanChair

Owner of Career Strategist

Sarah runs her own consulting firm, Career Strategist, and draws upon more than 20 years of recruitment and career development experience to help her global client base define new or existing career paths, or to help them navigate successfully in their current companies. In 2003, she was recognized by Boston Magazine one of the 100 most powerful women in Boston. Sarah is an accomplished and highly-regarded speaker and workshop leader. She conducts hands-on training and workshops for postdoctoral fellows, as well as companies, trade organizations, and associations. Her commitment and dedication to helping scientists, particularly postdocs, transform their career paths earned her the 2014 Mass AWIS Mentor of Excellence Award. Sarah has held leadership positions in many organizations including WEST, Mass Gap, Mass AWIS, South Shore Chamber, and Mass Alliance. She recently served on the Board of Directors of the Science Club for Girls (SCFG) and was the 2014 SCFG Catalyst Awards co-chair. Sarah is a founding Board Member of New England Women in Science Executives Club, and currently serves as Chair of the NEWISE Board.

Nicole Wagner
Nicole WagnerVice Chair

CEO, LambdaVision

Dr. Wagner obtained her PhD in Molecular and Cell Biology from the University of Connecticut under the advising of Dr. Robert Birge. Nicole entered the graduate program in 2007 and spent the majority of her graduate career working on optimizing retinal-containing proteins for application in devices. During the course of her PhD research, she played a critical role in the proof-of-concept experiments, which helped to found LambdaVision in May 2009. Through the use of site-directed mutagenesis, site-specific saturation mutagenesis, and directed evolution, Nicole was able to genetically engineer the protein, bacteriorhodopsin, for a variety of device applications, including protein-based holographic and 3-dimensional memories, a chemical detection sensor, and, most recently, a protein-based retinal implant.

Nicole is an accomplished scientist and entrepreneur with numerous peer-reviewed publications, and has presented her research at both National and International meetings. In 2012, Dr. Wagner received the Connecticut Technology Council’s Women of Innovation “Collegian Innovation and Leadership Award” for her work with LambdaVision, and most recently was listed as one of CT Magazine’s 40 under 40 for the class of 2015. Nicole currently serves as LambdaVision’s President and CEO. Since taking on the role of CEO, Dr. Wagner has been successful in securing over $2.5M in local, state, and government funding to accelerate the research, development, and commercialization of LambdaVision’s retinal implant.

LambdaVision is a UConn startup company founded to develop and manufacture a protein-based retinal implant to treat those blinded by macular degeneration and retinitis pigmentosa.

Karen Borofsky
Karen BorofskyTreasurer

Director of Administration, Lando & Anastasi, LLP

Karen has worked in Boston area law firms of various sizes for more than 30 years. She has promoted women’s initiatives within law firms and through her service to non-profit organizations throughout her career. Karen is a founding Board Member of NEWISE, and serves as Treasurer of the organization. Karen previously served for several years as a member of the Board of Directors of WEST. Karen received her undergraduate degree from Brandeis University and her M.B.A. from the Simmons College School of Business.

Laurie A. Halloran, BSN, MS
Laurie A. Halloran, BSN, MS Clerk

President & CEO Halloran Consulting Group, Inc.

Laurie Halloran founded Halloran Consulting Group in 1998, originally operating out of an unfinished bathroom. Her time as a pediatric ICU nurse had inspired her to start a company that helps move new therapies through FDA processes to get them into the hands of patients desperately in need. By providing a strategic development team, innovative start-up companies could have access to world-class expertise at a fraction of the cost. Since its humble beginnings, Halloran has grown into a successful consultancy of like-minded experts who are dedicated to improving human health by making life science companies better at what they do.

Laurie has been named 2018 Women’s Business Enterprise Star by the Women’s Business Enterprise National Council (WBENC) and has won a 2017 Enterprising Women of the Year Award from Enterprising Women Magazine. Halloran Consulting Group was also named an Inc. 5000Fastest Growing Company for the past three years in a row. In 2015, Laurie was honored by the Boston Business Journal as a Woman of Influence, in 2010 was selected as one of the 100 Most Inspiring People in Life Science by PharmaVoice, and in 2009, she was awarded Clinical Researcher of the Year by the New England Chapter of the Associate of Clinical Research Professionals.

Laurie lectures at Boston University Medical School and the Tufts Center for Drug Development Post-Graduate program. She has previously taught at George Washington University and Harvard University.  Laurie earned a Bachelor of Science in Nursing from Russell Sage College and a Master of Science in Management from Lesley University. She is also a Prosci Certified Change Practitioner.

Yael Schwartz
Yael SchwartzMember

Dr. Yael Schwartz is a Massachusetts life science executive and serial entrepreneur with a broad record of achievement amassed during 30+ years in pharmaceutical drug discovery and development.

Following her stint at Sepracor (Sunovion) where she worked on teams that developed Lunesta® for the treatment of insomnia, Brovana® for Chronic Obstructive Pulmonary Disease management, Xopenex® for the treatment of bronchoconstriction in asthma, she founded two companies, Hygeia Therapeutics and Canterbury Laboratories that were focused on woman’s health and dermatology. Both companies were acquired and taken public by RestorGenex (RESX). At RestorGenex she was the only woman on the Board of Directors and was the Executive VP of Preclinical Development.

In late 2015, following substantive disagreements pertaining to leadership and the overall direction of RestorGenex she submitted her resignation and flexed her entrepreneurial muscle again by founding Or-Genix Therapeutics, a company developing medical dermatology and aesthetic dermatology topical products for acne, aging skin, hair and mucous membranes. Under her leadership, Or-Genix raised more capital, filed new patents and entered into several commercial licensing deals.

Yael received her Bachelors degree from Salem State University, and entered the Master’s degree program in Pharmacology/Toxicology at Northeastern University. In 1991, Yael received her Ph.D. with honors in Human Endocrine Physiology from a joint program between the WPI Department of Biology/Biotechnology, Worcester, MA and the University of Massachusetts Medical School, Department of Physiology, Worcester, MA.

In 2014, she was nominated, by the Town of Holden’s Fire Chief, for the Madeline Amy Sweeney Award for Civilian Bravery for successfully rescuing and performing CPR on two children who nearly died in a backyard pool accident.

In 2015, Yael was recognized as a “Trail Blazer” and was featured in the WPI alumni magazine (Winter Edition) in an article titled “Skin Deep”.

Yael is the recipient of The Boston Business Journal Biotech Innovation All-Star Award.

For the past 10 years, Yael has served on the Board of Trustees of Massachusetts Biomedical Initiatives (MBI). She is co-founder of a non-profit organization for executive women in the healthcare sector, the NEWISE Club (New England Women in Science Executive’s Club), Boston, MA. She is an Honorary Member of Phi Lambda Sigma, The Pharmacy Leadership Society, for her teaching and mentorship activities at Massachusetts College of Pharmacy and Health Sciences.

For the two years she has been spending up to 10 hours a week at WPI in the Foisie School of Business as the Coleman Entrepreneur-in-Residence. In that capacity, she has provided inspiration, reality-checks and guidance for several new start-up companies.

Yael believes that true success is defined by how you handle the highs and lows of life, the difficult and the easy, while maintaining a sense of humor and purpose throughout.

Loving the challenges of entrepreneurship, she has no desire to retire, considers golf the most boring thing since white bread and prefers spending time with her husband, family and friends, hiking with her two dogs, Kaif and Bella, and competitive pistol shooting.

Iris Stammberger
Iris StammbergerMember

Iris Stammberger, MSEE, MED, PhD, is the founder and CEO of TALBOK Consulting LLC., a management consultancy that helps organizational leaders improve business performance by implementing lean, agile and design thinking management practices. In her work she relies on behavioral science principles that help sustain behavioral change at the individual and team level. She has worked internationally across a variety of industries – IT, biotech, pharmaceutical, energy, non-profit and higher education organizations. She holds degrees from Tufts University (Interdisciplinary Ph.D. (Cognitive Science) and Human Computer Interaction CAGS), Cambridge College (Counseling Psychology ME.d), IESA (Business Administration CAGS), Universidad Central de Venezuela (M.S. Electrical Engineering), and Universidad de Carabobo (BSEE). Iris is a mentor at the Healthcare Business Woman Association and a board member of the Boston Medical Development Group (Boston MDG), the New England Women in Science Executive Club (NEWISE Club) and the Boston Debate League. She recently received an award from WEST, a Cambridge-based organization where she teaches organizational excellence practices to women in engineering, science and technology. Contact information:

Betsy Ohlsson-Wilhelm
Betsy Ohlsson-WilhelmMember, ex oficio, and Chairman Emeritus
Diane Joseph-McCarthy
Diane Joseph-McCarthy Member

Diane Joseph-McCarthy has over 20 years of drug discovery and leadership experience in the pharmaceutical and biotechnology sector. She is currently Senior Vice President of Discovery & Early Development at EnBiotix. Before joining EnBiotix, she was an Associate Director in the Infection iMED at AstraZeneca, where she led an innovative group of scientists as well as a global team in Predictive Science. Prior to that she was at Wyeth where she held positions of increasing responsibility. She has been actively involved in the discovery of several compounds that have reached clinical trials. Dr. Joseph-McCarthy received her PhD from MIT and was a postdoctoral fellow at Harvard University and Harvard Medical School. She has more than 70 publications/patents and has given numerous invited talks. She also has served as a member of the National Academy of Sciences Polio Antiviral Advisory Committee.


The NEWISE CLUB offers a unique sponsorship opportunity for companies and organizations who seek to connect with senior life sciences executive women. By hosting one of our private monthly dinner gatherings, your organization’s senior leaders will have an opportunity to dine informally with our members.

Please visit our Sponsor page for more information or contact NEWISE leadership at